minoxidil |
38304-91-5 |
Rogaine |
Loniten |
Regaine |
Minoximen |
Theroxidil |
Lonolox |
6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide |
2,4-Pyrimidinediamine, 6-(1-piperidinyl)-, 3-oxide |
C9H15N5O |
U-10858 |
3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine |
CHEBI:6942 |
6-(piperidin-1-yl)pyrimidine-2,4-diamine 3-oxide |
Tricoxidil |
6-Amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine |
Alopexil |
Alostil |
MFCD00063409 |
Minodyl |
MLS000028566 |
Normoxidil |
Minossidile Italian |
Minoxidilum INN-Latin |
NCGC00015673-08 |
Minoxidilum |
SMR000058963 |
6-amino-2-imino-4-(piperidin-1-yl)-1,2-dihydropyrimidin-1-ol |
CAS-38304-91-5 |
Apo-Gain |
U10858 |
DSSTox_CID_20685 |
DSSTox_RID_79541 |
6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide |
DSSTox_GSID_40685 |
RiUP |
6-(1-piperidinyl)-2,4-pyrimidinediamine-3-oxide |
2,6-diamino-4-(piperidin-1-yl)pyrimidin-1-ium-1-olate |
Neoxidil |
Avacor and Mintop |
2,6-diamino-4-piperidylpyrimidin-1-ol |
SMR000326812 |
Loniten (TN) |
Rogaine (TN) |
Riup (TN) |
2,4-Diamino-6-piperidinopyrimidine 3-oxide |
SR-01000075331 |
SR-05000001479 |
3-oxido-6-piperidin-1-ylpyrimidin-3-ium-2,4-diamine |
U-10,858 |
Kopdil |
Regaine For Men |
Minoxidil,(S) |
Regaine For Women |
UNII-5965120SH1 |
Prestwick_521 |
3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine |
TM-160 |
Mens Rogaine" |
Womens rogaine |
6-amino-2-imino-4-(piperidin-1-yl)pyrimidin-1(2H)-ol |
Rogaine Extra Strength |
pyrimidin-1(2H)-ol |
Spectrum_000969 |
Tocris-0583 |
Minoxidil Extra Strength |
regid855572 |
Opera_ID_1150 |
Prestwick0_000020 |
Prestwick1_000020 |
Prestwick2_000020 |
Prestwick3_000020 |
Spectrum2_001053 |
Spectrum3_000509 |
Spectrum4_000063 |
Spectrum5_001299 |
Lopac-M-4145 |
M1389 |
CHEMBL802 |
M 4145 |
Minoxidil (JAN/USP/INN) |
CBiol_001798 |
Lopac0_000786 |
SCHEMBL29698 |
BSPBio_000059 |
BSPBio_001385 |
BSPBio_002037 |
KBioGR_000105 |
KBioGR_000585 |
KBioSS_000105 |
KBioSS_001449 |
MLS000859953 |
MLS001077294 |
DivK1c_000160 |
SCHEMBL232565 |
SPECTRUM1500415 |
SPBio_001006 |
SPBio_001980 |
BPBio1_000065 |
CHEMBL609587 |
GTPL4254 |
Minoxidil, >=99% (TLC) |
SGCUT00112 |
ZINC1735 |
CHEMBL1372483 |
DTXSID9040685 |
BCBcMAP01_000193 |
BDBM81463 |
CHEBI:92128 |
HMS500H22 |
KBio1_000160 |
KBio2_000105 |
KBio2_001449 |
KBio2_002673 |
KBio2_004017 |
KBio2_005241 |
KBio2_006585 |
KBio3_000209 |
KBio3_000210 |
KBio3_001537 |
NINDS_000160 |
BCPP000162 |
Bio1_000084 |
Bio1_000573 |
Bio1_001062 |
Bio2_000105 |
Bio2_000585 |
HMS1361F07 |
HMS1568C21 |
HMS1791F07 |
HMS1920P03 |
HMS1989F07 |
HMS2089L08 |
HMS2091F20 |
HMS2095C21 |
HMS2233E04 |
HMS2235N21 |
HMS3259P21 |
HMS3262M14 |
HMS3266O06 |
HMS3371E15 |
HMS3372M19 |
HMS3402F07 |
HMS3411G16 |
HMS3675G16 |
HMS3712C21 |
Pharmakon1600-01500415 |
ACT04612 |
BCP01409 |
CAS_4201 |
HY-B0112 |
NSC_4201 |
to_000070 |
ZINC6507066 |
Tox21_110193 |
Tox21_500786 |
3853AH |
BDBM50237593 |
CCG-40112 |
NSC757106 |
s1383 |
SBB056986 |
STL453211 |
AKOS015920078 |
AKOS016339636 |
Tox21_110193_1 |
6-amino-2-imino-4-(piperidin-1-yl) |
AC-5271 |
BCP9000929 |
CCG-220020 |
CS-1867 |
DB00350 |
GS-3605 |
KS-5164 |
LP00786 |
NC00686 |
NSC-757106 |
SDCCGSBI-0050764.P005 |
IDI1_000160 |
IDI1_033855 |
SMP1_000192 |
NCGC00015673-01 |
NCGC00015673-02 |
NCGC00015673-03 |
NCGC00015673-04 |
NCGC00015673-05 |
NCGC00015673-06 |
NCGC00015673-07 |
NCGC00015673-09 |
NCGC00015673-10 |
NCGC00015673-11 |
NCGC00015673-13 |
NCGC00015673-20 |
NCGC00018278-01 |
NCGC00018278-02 |
NCGC00018278-03 |
NCGC00018278-04 |
NCGC00024666-01 |
NCGC00024666-02 |
NCGC00024666-03 |
NCGC00024666-04 |
NCGC00024666-05 |
NCGC00024666-06 |
NCGC00024666-07 |
NCGC00024666-08 |
NCGC00179672-01 |
NCGC00261471-01 |
BD164673 |
H766 |
SBI-0050764.P004 |
AB0013244 |
AB0093459 |
2,6-Diamino-4-piperidinopyrimidine 1-Oxide |
5965120SH1 |
AB00513797 |
EU-0100786 |
FT-0620793 |
ST50993884 |
D00418 |
H10337 |
J10235 |
O10620 |
6-(1-Piperidinyl)-2,4-pyrimidinediamine3-oxide |
AB00052047-08 |
AB00052047_09 |
AB00052047_10 |
AB00513797-02 |
102666-EP2272841A1 |
102666-EP2281816A1 |
102666-EP2301936A1 |
304M915 |
A824098 |
Q424165 |
2,4-diamino-6-(1-piperidinyl)-pyrimidine-3-oxide |
Q-201408 |
SR-01000075331-1 |
SR-01000075331-3 |
SR-01000075331-5 |
SR-05000001479-1 |
SR-05000001479-2 |
3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine |
BRD-K06902185-001-05-2 |
BRD-K06902185-001-10-2 |
BRD-K14888893-001-02-3 |
Minoxidil, British Pharmacopoeia (BP) Reference Standard |
Z1541638524 |
Minoxidil, European Pharmacopoeia (EP) Reference Standard |
2-azanylidene-3-oxidanyl-6-piperidin-1-yl-pyrimidin-4-amine |
6-amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidino-pyrimidine |
Minoxidil, United States Pharmacopeia (USP) Reference Standard |
Minoxidil for system suitability, European Pharmacopoeia (EP) Reference Standard |